房颤患者显性与沉默性脑病变与认知功能的关系
该多中心研究纳入1737例已知房颤患者,行脑MRI与蒙特利尔认知评估(MoCA)。系统筛查发现大非皮质或皮质梗死(LNCCI)等脑病变负担高且多为临床沉默性,LNCCI与更差认知功能相关,即使沉默性梗死亦然。
要点
- 房颤患者系统脑MRI筛查中大非皮质或皮质梗死及其他脑病变负担高,且多数临床沉默。
- LNCCI患者MoCA低于无LNCCI者,仅限沉默性LNCCI时差异仍相似。
- 多变量模型中LNCCI体积是MoCA降低的最强预测因子。
核心结论
- 房颤患者系统脑MRI筛查中LNCCI及其他脑病变负担高,多数病变临床沉默。
- LNCCI与更差认知功能相关,即使临床沉默性梗死患者亦然。
- 研究结果提出是否应对房颤患者进行MRI筛查的问题。
研究设计与样本
- 瑞士多中心研究,纳入已知房颤患者1737例,平均年龄73±8岁,28%为女性,90%服用口服抗凝药。
- 全部参与者行脑MRI与MoCA认知测试,脑病变由中心核心实验室量化。
- 临床沉默性梗死定义为无卒中或短暂性脑缺血发作临床病史者的脑MRI梗死。
主要发现
- MRI上LNCCI 387例(22%),小非皮质梗死(SNCI)368例(21%),微出血372例(22%),白质病变1715例(99%)。
- 1390例无卒中或TIA病史者中,临床沉默性LNCCI 201例(15%),沉默性SNCI 245例(18%)。
- LNCCI者MoCA 24.7±3.3,无LNCCI者25.8±2.9(p<0.001);仅计沉默性LNCCI时24.9±3.1 vs. 25.8±2.9(p<0.001)。
- 多变量回归模型中LNCCI体积是MoCA降低的最强预测因子(β=-0.26;95%CI:-0.40至-0.13;p<0.001)。
临床怎么用
- 对房颤患者应关注认知功能,脑MRI所见的LNCCI(包括临床沉默性)与更差认知相关。
- 研究提示可考虑对房颤患者进行MRI筛查,但原文仅为提出问题,未给出筛查推荐。
- 口服抗凝药使用普遍(90%)背景下仍见高脑病变负担,提示需综合评估脑健康。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with atrial fibrillation (AF) have an increased risk of cognitive decline, potentially resulting from clinically unrecognized vascular brain lesions. OBJECTIVES: This study sought to assess the relationships between cognitive function and vascular brain lesions in patients with AF. METHODS: Patients with known AF were enrolled in a multicenter study in Switzerland. Brain magnetic resonance imaging (MRI) and cognitive testing using the Montreal Cognitive Assessment (MoCA) were performed in all participants. Large noncortical or cortical infarcts (LNCCIs), small noncortical infarcts (SNCIs), microbleeds, and white matter lesions were quantified by a central core laboratory. Clinically silent infarcts were defined as infarcts on brain MRI in patients without a clinical history of stroke or transient ischemic attack. RESULTS: The study included 1,737 patients with a mean age of 73 ± 8 years (28% women, 90% taking oral anticoagulant agents). On MRI, LNCCIs were found in 387 patients (22%), SNCIs in 368 (21%), microbleeds in 372 (22%), and white matter lesions in 1715 (99%). Clinically silent infarcts among the 1,390 patients without a history of stroke or transient ischemic attack were found in 201 patients with LNCCIs (15%) and 245 patients with SNCIs (18%). The MoCA score was 24.7 ± 3.3 in patients with and 25.8 ± 2.9 in those without LNCCIs on brain MRI (p < 0.001). The difference in MoCA score remained similar when only clinically silent LNCCIs were considered (24.9 ± 3.1 vs. 25.8 ± 2.9; p < 0.001). In a multivariable regression model including all vascular brain lesion parameters, LNCCI volume was the strongest predictor of a reduced MoCA (β = -0.26; 95% confidence interval: -0.40 to -0.13; p < 0.001). CONCLUSIONS: Patients with AF have a high burden of LNCCIs and other brain lesions on systematic brain MRI screening, and most of these lesions are clinically silent. LNCCIs were associated with worse cognitive function, even among patients with clinically silent infarcts. Our findings raise the question of MRI screening in patients with AF.
引用
- Conen D, Rodondi N, Müller A, et al. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2019. PMID: 30846109. doi:10.1016/j.jacc.2018.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。